Supernus Pharmaceuticals' FDA approval for ONAPGO in Parkinson's Disease offers optimism despite past challenges, with a ...

Commercials for the first Super Bowl in 1967 cost just $42,000 and big game spots didn’t surpass $1 million until the mid ...

Kura and Kyowa used the announcement to confirm that they are on track to file a new drug approval application with the FDA ...

The U.S. Food and Drug Administration has approved Axsome Therapeutics' Symbravo (meloxicam and rizatriptan) for the acute ...

Switching from beta-blockers to digoxin as first line therapy for older patients with AF could produce £100m in NHS savings annually.

The teleradiology service market is projected to grow from USD 6,221.2 million in 2023 to USD 22,069.5 million by 2033, ...

Bohemia is getting a little crowded — over one million copies of Kingdom Come: Deliverance 2 have been sold on the game's ...

(RTTNews) - RedHill Biopharma (RDHL) Tuesday announced that it has launched a Phase 2 trial to assess opaganib's ability to enhance darolutamide in treating metastatic castrate-resistant prostate ...

Genentech Inc. won regulatory approval Tuesday to market an eye implant that can be refilled every six months with an already ...

The FDA has approved the first and only subcutaneous apomorphine infusion device, apomorphine hydrochloride injection (Onapgo ...

Drug manufacturer Novo Nordisk's amycretin, an experimental weight-loss pill in clinical trials, may boast substantial weight ...